Engaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular

A large exercise of company stock options by George LeMaitre, Chairman and CEO at LeMaitre Vascular LMAT was disclosed in a new SEC filing on March 26, as part of an insider exercise.

What Happened: LeMaitre, Chairman and CEO at LeMaitre Vascular, exercised stock options for 14,808 shares of LMAT stock. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The exercise price of the options was $47.93 per share.

The latest update on Wednesday morning shows LeMaitre Vascular shares down by 0.0%, trading at $65.9. At this price, LeMaitre's 14,808 shares are worth $266,154.

All You Need to Know About LeMaitre Vascular

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Key Indicators: LeMaitre Vascular's Financial Health

Revenue Growth: LeMaitre Vascular's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 19.36%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Analyzing Profitability Metrics:

• Gross Margin: The company excels with a remarkable gross margin of 68.05%, indicating superior cost efficiency and profitability compared to its industry peers.

• Earnings per Share (EPS): LeMaitre Vascular's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.38.

Debt Management: LeMaitre Vascular's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.06.

Navigating Market Valuation:

• Price to Earnings (P/E) Ratio: LeMaitre Vascular's current Price to Earnings (P/E) ratio of 49.09 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.

• Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 7.62, LeMaitre Vascular's stock is perceived as being overvalued in the market, particularly in relation to sales performance.

• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Boasting an EV/EBITDA ratio of 28.24, LeMaitre Vascular demonstrates a robust market valuation, outperforming industry benchmarks.

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Pay Attention to Insider Transactions

Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.

In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

The Insider's Guide to Important Transaction Codes

Examining transactions, investors often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of LeMaitre Vascular's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.